OBJECTIVE: To obtain more insight into the process of potential implementation of a screening program, which aims to identify carriers of cystic fibrosis and haemoglobinopathies before pregnancy, in order to enable couples at high risk of having a child with these disorders, to make informed reproductive decisions. METHODS: Use of sociotechnical analysis, based on a model of co-evolution between technology and society, and, for comparison, the study of the implementation processes of two already existing health care programs with similar aspects to the screening program at issue. RESULTS: Factors important for success appeared to be the existence of sociotechnical niches, in which technological options can be developed and studied in an experimental setting; a structural approach of providing information to future parents; a party that can articulate demand; governmental involvement in the attunement between various stakeholders; and a screening infrastructure in which large-scale DNA diagnostic services are available. CONCLUSIONS: Successful implementation of preconceptional carrier screening for cystic fibrosis and haemoglobinopathies will depend on changes at both regime and landscape level, including the establishment of a new preconceptional health care setting and a clearly visible public health authority which can coordinate, monitor and evaluate such an initiative in public health care.
OBJECTIVE: To obtain more insight into the process of potential implementation of a screening program, which aims to identify carriers of cystic fibrosis and haemoglobinopathies before pregnancy, in order to enable couples at high risk of having a child with these disorders, to make informed reproductive decisions. METHODS: Use of sociotechnical analysis, based on a model of co-evolution between technology and society, and, for comparison, the study of the implementation processes of two already existing health care programs with similar aspects to the screening program at issue. RESULTS: Factors important for success appeared to be the existence of sociotechnical niches, in which technological options can be developed and studied in an experimental setting; a structural approach of providing information to future parents; a party that can articulate demand; governmental involvement in the attunement between various stakeholders; and a screening infrastructure in which large-scale DNA diagnostic services are available. CONCLUSIONS: Successful implementation of preconceptional carrier screening for cystic fibrosis and haemoglobinopathies will depend on changes at both regime and landscape level, including the establishment of a new preconceptional health care setting and a clearly visible public health authority which can coordinate, monitor and evaluate such an initiative in public health care.
Authors: B K Potter; D Avard; V Entwistle; C Kennedy; P Chakraborty; M McGuire; B J Wilson Journal: Public Health Genomics Date: 2008-09-03 Impact factor: 2.000
Authors: Frauke Becker; Carla G van El; Dolores Ibarreta; Eleni Zika; Stuart Hogarth; Pascal Borry; Anne Cambon-Thomsen; Jean Jacques Cassiman; Gerry Evers-Kiebooms; Shirley Hodgson; A Cécile J W Janssens; Helena Kaariainen; Michael Krawczak; Ulf Kristoffersson; Jan Lubinski; Christine Patch; Victor B Penchaszadeh; Andrew Read; Wolf Rogowski; Jorge Sequeiros; Lisbeth Tranebjaerg; Irene M van Langen; Helen Wallace; Ron Zimmern; Jörg Schmidtke; Martina C Cornel Journal: Eur J Hum Genet Date: 2011-04 Impact factor: 4.246
Authors: Tessel Rigter; Lidewij Henneman; Jacqueline E W Broerse; Maggie Shepherd; Ignacio Blanco; Ulf Kristoffersson; Martina C Cornel Journal: J Community Genet Date: 2014-06-04
Authors: Lieke M van den Heuvel; Nina van den Berg; A Cecile J W Janssens; Erwin Birnie; Lidewij Henneman; Wybo J Dondorp; Mirjam Plantinga; Irene M van Langen Journal: Eur J Hum Genet Date: 2022-09-12 Impact factor: 5.351
Authors: Ivy van Dijke; Carla G van El; Phillis Lakeman; Mariëtte Goddijn; Tessel Rigter; Martina C Cornel; Lidewij Henneman Journal: PLoS One Date: 2022-06-21 Impact factor: 3.752
Authors: Suze M P J Jans; Ank de Jonge; Lidewij Henneman; Martina C Cornel; Antoinette L M Lagro-Janssen Journal: Eur J Hum Genet Date: 2012-05-02 Impact factor: 4.246
Authors: Suze M P J Jans; Carla G van El; Eddy S Houwaart; Marjan J Westerman; Rien J P A Janssens; Antoinette L M Lagro-Janssen; Anne Marie C Plass; Martina C Cornel Journal: Ethn Health Date: 2011-08-08 Impact factor: 2.772
Authors: Martina C Cornel; Johan J P Gille; J Gerard Loeber; Annette M M Vernooij-van Langen; Jeannette Dankert-Roelse; Piet A Bolhuis Journal: J Inherit Metab Dis Date: 2012-07 Impact factor: 4.982
Authors: Stephanie S Weinreich; Elly Sm de Lange-de Klerk; Frank Rijmen; Martina C Cornel; Marja de Kinderen; Anne Marie C Plass Journal: BMC Public Health Date: 2009-09-15 Impact factor: 3.295